Melodie Young, MSN, RN, ANP-C: Practical Aspects of Treating Patients with Atopic Dermatitis
![](https://jcad.tv/wp-content/uploads/2024/07/Melodie-Young-EP-in-AD-NPPA-September-1024x576.jpg)
Melodie Young discusses the logistics of gaining access to newer medications through speciality pharmacies for patients with atopic dermatitis.
Andrea Nguyen, PA-C, MS: Treatment Education for Patients with Atopic Dermatitis
![](https://jcad.tv/wp-content/uploads/2024/05/Andrea-Nguyen-May-Thumbnail-1024x576.jpg)
Andrea Nguyen, PA-C, MS, discusses how the internet and social media has contributed to more in-depth discussion with her patients regarding treatment for atopic dermatitis.
TJ Chao, PA-C: Considering Adverse Events in Patients with Atopic Dermatitis
![](https://jcad.tv/wp-content/uploads/2024/01/TJ-Chao-EP-Thumbnail-v1-1024x576.jpg)
TJ Chao breaks down the black box warnings for ruxolitinib cream 1.5% and discusses the importance in communicating the specifics of these warnings to patients.
TJ Chao, PA-C: Utilizing Topical Treatments for Patients with Atopic Dermatitis
![](https://jcad.tv/wp-content/uploads/2024/01/TJ-Chao-EP-Thumbnail-v1-1024x576.jpg)
Mr. Chao discusses the reliability of ruxolitinib cream 1.5% in treating patients with atopic dermatitis. He emphasized how well it is tolerated by patients, as it does not cause any stinging or burning.
Matthew Zirwas, MD: Revolution of Topical Treatments in Atopic Dermatitis
![](https://jcad.tv/wp-content/uploads/2023/11/Matt-Zirwas-EP-Thumbnail-1024x576.jpg)
Dr. Matthew Zirwas reviews atopic dermatitis treatments that have been essential in providing immediate improvement in itch leading to a sense of control in his patients. He details the effectiveness in drugs such as using ruxolitinib, roflumilast, and tapinarof that have changed the way he treats AD.